Skip to main content

Advertisement

Table 2 Patient characteristics (n = 130)

From: Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer

Characteristic Value or No. of patients (%)
Age, years
Median 74
Range 48–91
FEV1, % of predicted
Median 42
Range 15–123
Staging PET SUVmax
Median 6.20
Range 0.5–32.6
Gross tumor volume, cm3
Median 9.6
Range 0.7–51.47
Planning target volume, cm3
Median 73.2
Range 23.36–109.64
Sex
Men 67 (51.5)
Women 63 (48.5)
COPD stage
0-II 73 (56)
III-IV 57 (44)
History of other types of cancer
Yes 37 (28.5)
No 93 (71.5)
ECOG performance status
0 or 1 81 (62)
2 or 3 49 (38)
Lung cancer stage
IA (T1) 112 (86)
IB (T2) 18 (14)
Lung cancer histology
Squamous cell carcinoma 36 (28)
Adenocarcinoma 58 (45)
NSCLC not specified 36 (28)
Disease status
Medically inoperable 96 (74)
Operable 34 (26)
Tumor location
Peripheral 119 (91.5)
Central 11 (8.5)
  1. Abbreviations: FEV1, forced expiratory volume in 1 second; PET, positron emission toography; SUVmax, maximum standardized uptake value; COPD, chronic obstructive pulmonary disease; ECOG, Eastern Cooperative Oncology Group; NSCLC, non-small cell lung cancer;